Close mobile menu×
Close mobile menu

Paul J. Gaglio, MD, FACP

Board Certifications: 
Gastroenterology, Internal Medicine, Transplant Hepatology
Accepting New Patients
Profile Headshot

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

America's Top Doctor

Board Certifications

  • Gastroenterology
  • Internal Medicine
  • Transplant Hepatology

Clinical Expertise

  • Cirrhosis
  • Fatty Liver
  • Hepatology
  • Liver Disease
  • Liver Transplant
  • Portal Hypertension
  • Transplant Hepatology
  • Viral Hepatitis

Education & Training

  • 1988 UMDNJ - New Jersey School of Medicine
  • Internship: 1989 Mount Sinai Medical Center
  • Residency: 1991 Mount Sinai Medical Center
  • Fellowship: 1993 UMDNJ-New Jersey Medical School Digestive Diseases, Gastroenterology, Hepatology and Liver Transplantation

Honors & Awards

2009-2020 “Best Doctors® in America”
2012-2020 Castle Connolly Top Doctors; New York Metro Area 2012-2020
2013-2020 Marquis Who's Who In America 2013-2020
2014 Fellow American Association for the Study of Liver Disease
2011 Physician of the Year, New York Chapter, American Liver Foundation
2008 Fellow American Gastroenterological Association
2001 Fellow American College of Physicians
2001 Surgical Houstaff Teaching Award Tulane University

About Paul Gaglio

Paul J. Gaglio, MD FACP, AGAF, FAASLD, Professor of Medicine (in Surgery) is the newly appointed director of Hepatology Outreach at NY-Presbyterian Hospital, Columbia University Irving Medical Center. He is the former medical director of Adult Liver Transplantation at The Montefiore Medical Center, Columbia Presbyterian Hospital, and The Tulane University Medical Center. Dr. Gaglio received his bachelor’s in Biology/Physiology from Rutgers College in New Brunswick, NJ, and his M.D. from UMDNJ-New Jersey Medical School. He completed an internship and residency at Mount Sinai Medical Center in New York City, and a digestive disease/liver transplantation fellowship at New Jersey Medical School. Dr. Gaglio has published multiple manuscripts, book chapters, and abstracts, and has participated in numerous research trials related to the therapy of hepatitis B and C, liver transplantation, and treatment of liver failure. Dr. Gaglio has lectured nationally and internationally on these topics. He is a Fellow of the American College of Physicians, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases. His research interests include treatment of hepatitis B and C, the natural history of hepatitis C in liver transplant recipients, and non-alcoholic fatty liver disease. He is consistently listed in Castle Connolly Top Doctors; NY Metro Area, Marquis Who’s Who in America, and has received several teaching awards. In 2011, he was named Physician of the Year, NY Chapter of the American Liver Foundation.

Academic Titles

  • Professor of Medicine (in Surgery) at CUMC

Administrative Positions

  • Director, Hepatology Outreach

Committee/Societies/Council Memberships

  • American Association for the Study of Liver Disease
  • European Association for the Study of the Liver
  • American Society of Transplantation
  • American Liver Foundation
  • American Gastroenterology Association
  • International Liver Transplantation Society
  • International Hepatitis Society
  • United Network for Organ and Tissue Sharing; Liver Transplantation
  • American Foundation for Medical Research
  • Columbia University Department of Medicine Executive Committee
  • Columbia University Liver Transplantation Selection Committee
  • American College of Physicians
  • New York Consortium for Liver Transplantation
  • Empire Liver Foundation Medical Advisory Board
  • Hep C Link to Care Initiative NYC Medical Advisory Board

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Insurance Accepted

For billing questions, please call (212) 305-8582.

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

Research

Selected Publications

  1. Thompson J, Jones N, Al-Khafaji A, Gaglio P, et al VTI-208 Study Group.Extracorporeal Cellular Therapy (ELAD) in Severe Alcoholic Hepatitis - A Multinational, Prospective, Controlled, Randomized Trial. Liver Transplantation 2018;24:380-393
  2. Lubetzky, M, Soowan C, Joelson A, Coco M, Kamal L, Ajaimy M, Gaglio PJ, Akalin E and Deboccardo G Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents Transplantation. 2017;101(7):1704-1710
  3. Izzy M, Jibara G, Aljanabi A, Alani M, Giannattasio E, Zaidi H, Said Z, Gaglio P, Wolkoff A, Reinus JF. Limited Fibrosis Progression but Significant Mortality in Patients Ineligible for Interferon-Based Hepatitis C Therapy. J Clin Exp Hepatol. 2016;6(2):100-8
  4. Zahiruddin A, Farahmand A, Gaglio P, Massoumi H.Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population. Gastroenterol Hepatol Bed Bench. 2016;9(3):225-30.
  5. Jermyn R, Soe E, D'Alessandro D, S
  6. hin J, Jakobleff W, Schwartz D, Kinkhabwala M, Gaglio PJ. Cardiac failure after liver transplantation requiring a biventricular assist device. Case Rep Transplant. 2014;2014:946961
  7. Tandan S, Sun K, Gaglio PJ A Rare Finding on Liver Explant. Clin Gastroenterol Hepatol. 2014 Sep;12(9):e85
  8. Bichoupan K, Schwartz JM, Martert V, Giannattasio ER, Marfo K, Odin J, Liu L, Schiano T, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich D, Branch A, Reinus JP. Effect of Fibrosis on Adverse Events in Hepatitis C Patients treated with Telaprevir Aliment Pharmacol Ther. 2014;39:209-216.
  9. Kinkhabwala M, Lindower J, Principe AL, Reinus J, Gaglio PJ. Expedited Liver Allocation in the US: A Critical Analysis. Liver Transplantation 2013;19(10):1159-65
    Gaglio PJ, Marfo K, Chiodo J. Hyponatremia in Cirrhosis and End Stage Liver Disease; Treatment with the Vasopressin V2 Receptor Antagonist Tolvaptan: Dig Dis Sci. 2012 Nov;57(11):2774-8
  10. Flattau, A, Gaglio PJ, et al. Social Bariers to Adult Liver Transplantation Listing; Prevalence and Association with Program Characteristics: Liver Transpl. 2011;17:1167-1175
  11. Degertekin B, Han SH, Keeffe EB, Gaglio PJ. Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.; NIH HBV-OLT Study Group. Am J Transplant. 2011;10:1823-33
  12. Gaglio PJ, Moss N, McGaw C, Reinus J Direct Acting Antiviral Therapy for Hepatitis C; Attitudes Regarding Future Use: Dig Dis Sci. 2011;56:1509-15.